Lab Ops and Facility Management for Biopharma Summit

The last 3 years continue to see California rising as a competing biotech hub, incubating fast-growing biopharma and becoming a favored satellite site to large pharma in the West Coast. Notable developments include Moderna leasing a new campus in Seattle, Fred Hutchinson Cancer Center opened a $320m campus, and Gilead's new research center underway.

However, lingering market volatility simply means lab operations managers within fast-growing biopharma in the West Coast need to be even more adept at business operations, as they play the critical role to the health of R and D pipeline progression and business continuity in 2024.

As part of the flagship LAFM community, the premier Lab Operations and Facility Management for Biopharma Summit is here to provide the much-needed support for lab ops experts within mid-sized biotechs. Bringing together over 60 leaders this May in San Diego and in collaboration with Merck, BioMarin and Nanoimaging, we look forward to helping you to:
- Increase spend visibility and explore saving opportunities to increase capital efficiency
- Achieve agility through balancing short-term needs, mid-term growth and long-term uncertainty from a lab space and facility management perspective
- Equip you with the critical financial planning and risk assessment knowledge, and bridge the gap between scientific and operational teams
- Adopt novel models with your lab asset vendors and OEMs, as well as integrated FMs services to improve productivity and cost-effectiveness

As lab managers and facility management leaders continue to spin multiple hats in 2024, this is your must-attend forum, arming you with the R and D lab ops knowledge which will be pivotal to your pipeline and organization's success. Join us to network, benchmark, and reclaim time back for scientists!

URLs:
Tickets: https://go.evvnt.com/2261779-0?pid=10018
Website: https://go.evvnt.com/2261779-2?pid=10018
Brochure: https://go.evvnt.com/2261779-3?pid=10018

Prices:
Drug Developers, CDMO, CRO and Diagnostics - Conference + 2 Workshops: USD 3497.00,
Drug Developers, CDMO, CRO and Diagnostics - Conference + 1 Workshop: USD 3048.00,
Drug Developers, CDMO, CRO and Diagnostics - Conference Only: USD 2599.00,
Solution Provider - Conference + 2 Workshops: USD 5097.00,
Solution Provider - Conference + 1 Workshop: USD 4398.00,
Solution Provider - Conference Only: USD 3699.00

Speakers: Adrianne Pittman, Lab Manager, Life Edit Therapeutics, Andrew Ramsay, Lab Manager, Outpace, Christopher Sakoda, Biotechnology Laboratory Manager, Appia Bio, David Chen, Laboratory Operations Manager, Evercrisp Biosciences, David Roberts, Executive Director of Laboratory Operations, Alexandria Launch Labs, Jonathan Haag, Laboratory Operations Manager, Vitalant Research Institute, Juhi Naik, Operations Manager, Chan Zuckerberg Biohub, Kimberly Samayoa, Associate Director, Discovery Operations Lead, Merck, Marilyn Sanchez, Manager, Lab Operations, Seattle Children's Hospital, Peter Gil, Lab Operations, Earli, Pruthvi Shah, Senior Laboratory Operations Manager, Nkarta, Rick Hernandez, Laboratory Operations Manager, Climax Foods, Saboor Hekmaty, Director, Laboratory Operations, Avrok Biosciences, Steven Chung, Research Associate, Gilead Sciences, Steven Doran, Senior Manager, Operations, Stemson Therapeutics, Tamanna Talukder, Clinical Laboratory Scientist/Quality Assurance, Avrok Biosciences, Yi Liu, Lab Operations Manager, Energy Biosciences Institute